ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth vs Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth appears stronger based on its higher star rating of 5 compared to the 2-star rating of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth, indicating better performance or management quality. However, while Kotak's expense ratio is lower at 0.2012%, it has significantly lower returns over the 1-year and 3-year periods compared to ICICI's 24.97% and 21.58%, respectively. Investors should weigh the tradeoff between higher potential returns with ICICI's fund against the lower costs and higher rating of Kotak's fund.

ICICI Prudential Mutual Fund

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

ICICI Prudential Mutual Fund

★★★★★

Other · Index Funds

Kotak Mahindra Mutual Fund

Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth

Kotak Mahindra Mutual Fund

★★★★★

Other · Index Funds

Metric ICICI Prudential Nifty... Kotak Nifty SDL Apr 20...
NAV ₹21.96 ₹13.39
Star Rating ★★ ★★★★★
Expense Ratio 0.51% 0.2012%
AUM ₹163 Cr ₹6,136 Cr
1M Return +10.74% +0.62%
3M Return +7.74% +1.28%
6M Return +14.27% +2.88%
1Y Return +24.97% +5.84%
3Y CAGR +21.58% +7.48%
Risk Level — —
Fund Manager Nishit Patel Abhishek Bisen